Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

(2015)   JOURNAL OF HEPATOLOGY

Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation

(2012) R. Todd Stravitz et al.   LIVER INTERNATIONAL

Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: A European multicenter study

(2011) Si-Nafa Si-Ahmed et al.   ANTIVIRAL RESEARCH

Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV

(2011) A. Fabarius et al.   BLOOD

Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation

(2011) James Fung et al.   GASTROENTEROLOGY

High Rate of Complete Viral Suppression With Combination Therapy in Patients With Chronic Hepatitis B and Prior Treatment Failure

(2011) Carrie R. Wong et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Tenofovir Therapy in Hepatitis B Virus-Positive Solid-Organ Transplant Recipients

(2011) Mathieu Daudé et al.   TRANSPLANTATION

Liver transplantation for hepatitis B: What is the best hepatitis B immune globulin/antiviral regimen?

(2010) Peter W. Angus et al.   LIVER TRANSPLANTATION

HBIg Discontinuation with Maintenance Oral Anti-viral Therapy and HBV Vaccination in Liver Transplant Recipients

(2009) Nicholas K. Weber et al.   DIGESTIVE DISEASES AND SCIENCES

Chronic hepatitis B: Update 2009

(2009) Anna S. F. Lok et al.   HEPATOLOGY

EASL Clinical Practice Guidelines: Management of chronic hepatitis B

(2008)   JOURNAL OF HEPATOLOGY

What is the optimal regimen for preventing hepatitis B recurrence after liver transplantation?

(2008) Bulent Degertekin et al.   Nature clinical practice. Gastroenterology & hepatology